$0.97
-0.05 (-4.89%)
USD · as of 2026-08-18 · marketstack
Clinical trials
catalyst calendar across sponsors →Studies where BJDX is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
7 observational
Held by 0 tracked-famous managers · FINRA short interest 1.0 days to cover (settled 2026-07-31) · government filings 180d: none disclosed
| Study | Phase | Status | Conditions | Enrollment | Primary completion | Readout in | Updated |
|---|---|---|---|---|---|---|---|
| Multicenter Symphony™ IL-6 Monitoring Sepsis ED Pilot StudyNCT07425587observationalSepsis (according to the Third International Consensus Definitions (Sepsis-3 criteria)) within 3 days after inclusion. | — | Recruiting | Sepsis, Septic Shock | 450 | 2026-12-30 | in 133 d | 2026-07-02 |
| Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation StudyNCT06654895observational28-day all-cause mortality [Time Frame: within 28 days after inclusion] participants will be followed up for 28 days | — | Active, not recruiting | Sepsis, Septic Shock | 700 | 2026-09-30 | in 42 d | 2026-08-19 |
| Symphony IL-6 Cutoff Validation Study for Patients at Risk of Severe SepsisNCT05048927observationalValidation of IL-6 Cutoff for Patients at High Risk of Severe Sepsis | — | Unknown status | Severe Sepsis | 48 | 2024-11-30 | — | 2023-08-14 |
| Symphony IL-6 Cutoff Establishment Study for Patients at Risk of Severe Sepsis Due to COVID-19NCT05060250observationalMeasurement of IL-6 Concentration in Patients at High Risk of Severe Sepsis | — | Unknown status | Severe Sepsis | 96 | 2024-11-30 | — | 2023-08-15 |
| Symphony IL-6 Study in Patients at Risk of Severe SepsisNCT05665153observationalConcentration of IL-6 in hospitalized patients with COVID-19 and/or Influenza who require invasive mechanical ventilation | — | Unknown status | Severe Sepsis | 200 | 2024-08-21 | — | 2023-09-07 |
| Multicenter Symphony IL-6 Monitoring Sepsis ICU StudyNCT06181604observational28-day all-cause mortality | — | Completed | Sepsis, Septic Shock | 143 | 2024-07-12actual | — | 2025-08-03 |
| Symphony IL-6 Reference Range StudyNCT05048888observationalIL-6 Reference Range Study | — | Unknown status | Sepsis | 120 | 2024-03-30 | — | 2023-08-14 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19